fosamax lawsuit

On October 13, 2010, the U.S. Food and Drug Administration (FDA) issued a femur fracture warning informing patients and well being care providers about the doable threat of atypical thigh bone (femur) fractures in patients who take bisphosphonates, such as Fosamax.  Bisphosphonates are a class of drugs employed to avoid and treat osteoporosis. Atypical femur fractures, a rare but serious kind of thigh bone fracture, have been predominantly reported in patients taking drugs such as Fosamax for longer than 5 years.

A labeling adjust and Medication Guide for Fosamax, Fosamax Plus D, and their generic merchandise will reflect this newest femur fracture warning by the FDA.
Studies Help Femur Fracture Warning

With regard to this femur fracture warning, the FDA stated that it is &ldquocontinuing to evaluate information about the safety and effectiveness of bisphosphonates when utilized extended-term for osteoporosis remedy.&rdquo &ldquoIn the interim, it&rsquos important for patients and wellness care experts to have all the safety data obtainable when figuring out the ideal course of treatment for osteoporosis.&rdquo

These days&rsquos femur fracture warning follows a March 10, 2010 Drug Safety Communication announcing the FDA&rsquos ongoing safety review of bisphosphonate use and the occurrence of atypical femur fractures. The FDA has because reviewed all available information on bisphosphonate use, which includes information summarized in the American Society for Bone Mineral Investigation Process Force report. The report suggested additional item labeling, much better identification and tracking of patients experiencing these breaks, and a lot more study to figure out regardless of whether and how these drugs lead to the critical but uncommon fractures.

Based on the FDA&rsquos evaluation, the Warnings and Precautions section of all bisphosphonate items for osteoporosis, including Fosamax, will be revised to include the femur fracture warning, and the FDA will call for the inclusion of the very same femur fracture warning into a Medication Guide to better inform patients of the achievable increased fracture danger. People who have suffered a femur fracture after taking Fosamax may want to file a fosamax lawsuit.

Given this latest femur fracture warning, the FDA recommends that well being care pros be aware of the achievable danger in patients taking bisphosphonates and take into account periodic reevaluation of the want for continued bisphosphonate therapy for patients who have been on bisphosphonates for longer than five years.

Patients taking bisphosphonates must report any new thigh or groin discomfort to their health care provider and be evaluated for a doable femur fracture. If you or someone you know have suffered a femur fracture after taking Fosamax contact a fosamax lawyer for help.